Insiders · Profile

Aslan Fred

Chief Executive Officer at Artiva Biotherapeutics. Filing since 15 Aug 2025. CIK 0001909362

Company

Date

Role

Action

Shares

Amount

Of holding

ARTV Artiva Biotherapeutics, Inc.

6 Oct 2026

Chief Executive Officer

Sold on a plan

23,463

$168.88K

1.5%

ARTV Artiva Biotherapeutics, Inc.

5 Oct 2026

Chief Executive Officer

Sold at will

61,696

$421.83K

3.8%

ARTV Artiva Biotherapeutics, Inc.

8 Sep 2026

Chief Executive Officer

Sold on a plan

23,429

$255.75K

1.6%

ARTV Artiva Biotherapeutics, Inc.

3 Sep 2026

Chief Executive Officer

Sold at will

61,888

$690.39K

4.0%

ARTV Artiva Biotherapeutics, Inc.

19 May 2026

Chief Executive Officer

Sold at will

27,116

$244.25K

1.7%

ARTV Artiva Biotherapeutics, Inc.

15 Dec 2025

President and CEO

Sold on a plan

3,187

$19.12K

0.3%

ARTV Artiva Biotherapeutics, Inc.

17 Nov 2025

President and CEO

Sold on a plan

6,375

$21.52K

1.8%

ARTV Artiva Biotherapeutics, Inc.

17 Oct 2025

President and CEO

Sold on a plan

25,500

$153.00K

6.7%

ARTV Artiva Biotherapeutics, Inc.

15 Aug 2025

President and CEO

Sold on a plan

25,500

$69.58K

6.2%

9 decisions on file.